Concepedia

Author

Halvard Bönig

Goethe University FrankfurtORCID

Also Known As

Bonig, Halvard, Bönig, Bönig, H., H B Bönig, H Bonig, H Bönig, H. Bonig, H. Bonig*, H. BÖNIG, H. Bönig

365

Publications

9K

Citations

52

H-Index

140

Concepts

All Affiliations

Goethe University FrankfurtGerman Red CrossUniversity of WashingtonHeidelberg UniversityUniversity Hospital Frankfurt
HB

About

Halvard Bönig is an author at Goethe University Frankfurt specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

27

49

2.2K

2

Health Sciences

13

14

812

3

Engineering

3

3

86

4

Natural Sciences

2

2

30

5

Public Health

2

2

68

Halvard Bönig

×

150

Publications

7.7K

Citations

48

H-Index

YearCitations

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

Patrick Hayden, Claire Roddie, Peter Bader,

Annals of Oncology

2021

389

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

Ibrahim Yakoub‐Agha, Christian Chabannon, Peter Bader,

Haematologica

2019

343

Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor

Kurt Schönfeld, Christiane Sahm, Congcong Zhang,

Molecular Therapy

2014

337

Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B

Wolfgang Miesbach, Karina Meijer, Michiel Coppens,

Blood

2017

295

Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers

Verena Köberle, Thomas Pleli, Christian Schmithals,

PLoS ONE

2013

193

CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib

Hardikkumar Jetani, Irene García‐Cadenas, Thomas Nerreter,

Leukemia

2018

183

Spleen Size Is Significantly Influenced by Body Height and Sex: Establishment of Normal Values for Spleen Size at US with a Cohort of 1200 Healthy Individuals

Kai Uwe Chow, Beate Luxembourg, Erhard Seifried,

Radiology

2015

173

Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab

Halvard Bönig, Annette Wundes, Kai-Hsin Chang,

Blood

2008

170

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma

Sabrina Prommersberger, Michael Reiser, Julia Beckmann,

Gene Therapy

2021

170

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Michael Neuenhahn, Julia Albrecht, Marcus Odendahl,

Leukemia

2017

158

Page 1